Acute toxicity of concurrent adjuvant radiotherapy and chemotherapy (CMF or AC) in breast cancer patients - a prospective, comparative, non-randomised study

Author： Fiets W.E.   van Helvoirt R.P.   Nortier J.W.R.   van der Tweel I.   Struikmans H.  

Publisher： Elsevier

ISSN： 0959-8049

Source： European Journal of Cancer, Vol.39, Iss.8, 2003-05, pp. : 1081-1088

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Epirubicin versus CMF as adjuvant therapy for stage I and II breast cancer: a prospective randomised study

By Colozza M.   Bisagni G.   Mosconi A.M.   Gori S.   Boni C.   Sabbatini R.   Frassoldati A.   Passalacqua R.   Bian A.R.   Rodino C.   Rondini E.   Algeri R.   Di Sarra S.   De Angelis V.   Cocconi G.   Tonato M.   on behalf of the Italian Oncology Group for Clinical Research GOIRC  

European Journal of Cancer, Vol. 38, Iss. 17, 2002-11 ,pp. : 2279-2288

Elsevier

Access to resources Recommend Favorite

Eight-year results of a prospective non-randomised study on therapy of small breast cancer

By Rauschecker H.F.   Sauerbrei W.   Gatzemeier W.   Sauer R.   Schauer A.   Schmoor C.   Schumacher M.  

European Journal of Cancer, Vol. 34, Iss. 3, 1998-02 ,pp. : 315-323

Elsevier

Access to resources Recommend Favorite

Health-Related Quality of Life in Axillary Node-Negative, Estrogen Receptor-Negative Breast Cancer Patients Undergoing AC Versus CMF Chemotherapy: Findings from the National Surgical Adjuvant Breast and Bowel Project B-23

By Land Stephanie   Kopec Jacek   Yothers Greg   Anderson Stewart   Day Richard   Tang Gong   Ganz Patricia   Fisher Bernard   Wolmark Norman  

Breast Cancer Research and Treatment, Vol. 86, Iss. 2, 2004-07 ,pp. : 153-164

Springer Publishing Company

Access to resources Recommend Favorite

Adjuvant dose-dense sequential chemotherapy with epirubicin, CMF, and weekly docetaxel is feasible and safe in patients with operable breast cancer

By Fountzilas George   Pectasides Dimitrios   Christodoulou Christos   Timotheadou Eleni   Economopoulos Theofanis   Papakostas Pavlos   Papadimitriou Christos   Gogas Helen   Efstratiou Ioannis   Skarlos Dimosthenis  

Medical Oncology, Vol. 23, Iss. 4, 2006-12 ,pp. : 479-488

Humana Press, Inc

Access to resources Recommend Favorite

Hepatic toxicity caused by adjuvant CMF/CNF in breast cancer patients and reversal by tamoxifen

By Hirvikoski P.P.   Kumpulainen E.J.   Johansson R.T.  

Breast Cancer Research and Treatment, Vol. 44, Iss. 3, 1997-07 ,pp. : 269-274

Springer Publishing Company

Access to resources Recommend Favorite